Sbi Securities Co., Ltd. Indaptus Therapeutics, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Indaptus Therapeutics, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 3,900 shares of INDP stock, worth $3,237. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,900Holding current value
$3,237% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INDP
# of Institutions
18Shares Held
605KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA256KShares$212,6990.0% of portfolio
-
Investment House LLC Las Vegas, NV100KShares$82,9800.01% of portfolio
-
Geode Capital Management, LLC Boston, MA73.1KShares$60,6970.0% of portfolio
-
Strategy Asset Managers LLC45.3KShares$37,6280.01% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ43.9KShares$36,4540.0% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $6.85M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...